查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1454118

重组抗体市场，按类型、按应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Recombinant Antibodies Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年重组抗体市场规模为 121.1 亿美元，2024 年至 2032 年CAGR为 6.5%。

重组抗体市场-市场动态

癌症和传染病病例的增加推动市场成长

在预测期内，由于全球传染病和癌症病例发生率上升，重组抗体市场预计将成长。透过识别并附着在癌细胞表面表达的抗原，重组抗体被设计为精确靶向癌细胞。与传统化疗相比，这种集中的方法减少了副作用并减少了对健康细胞的伤害。这也可用于被动免疫，提供针对传染性病原体的即时防御。它们可以提供给那些处于危险中或已经受到感染的人，例如在某些病毒流行的情况下，因为它们的设计类似于免疫反应。例如，根据全球癌症观测站 (GLOBOCAN) 的估计，2020 年全球将有 1,930 万例癌症病例。印度排名第三，仅次于美国和中国。 2040年，印度将新发现208万例癌症病例，比2020年增加57.5%。

重组抗体市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.5% 左右的CAGR成长

根据类型细分，单链抗体细分市场预计将在预测期内占据最大的收入份额

根据应用细分，製药和生物技术领域预计将在预测期内主导市场

从地区来看，预计北美将在预测期内主导市场

重组抗体市场-細項分析：

全球重组抗体市场根据类型、应用和地区进行细分。

依类型，重组抗体市场分为单股抗体、全人抗体、人源化抗体、嵌合抗体及双特异性抗体。预计单链抗体细分市场将在预测期内占据最大的收入份额。重组DNA技术用于製造单链抗体，能够改变结合特异性和亲和力。这一特性提高了它们针对与一系列疾病相关的特定抗原的适应性。由于 scFv 分子比典型抗体更小、结构更简单，因此在某些情况下很有用。较小的尺寸可以实现更大的组织穿透力，这可能会带来更好的治疗效果。

根据应用，全球重组抗体市场分为医院和诊断实验室、製药和生物技术、研究机构等。预计製药和生物技术领域将在预测期内主导市场。主要製药和生技公司大力投资重组抗体相关的研发活动。因此，推动了细分市场的扩张。

重组抗体市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内主导市场。区域市场的扩张归因于主要参与者的存在。此外，癌症和其他传染病患者的上升极大地推动了该地区的市场成长。

重组抗体市场-竞争格局：

市场的主要参与者包括 Bio-Rad Laboratories、GE Healthcare、F. Hoffmann-La Roche、BIOLEGEND、BD Biosciences、Creative Biolabs、Merck KGaA、Abnova、Abcam、SinoBiological、BBI Solutions、ProMab Biotechnologies 和 Beckman Coulter。这些参与者采取了各种策略来获得行业的主要市场份额，包括产品发布、收购、合作等。

最近的发展：

2023 年 11 月，Lonza 宣布启用其新的 GS Effex(R)细胞株，以促进更有效的治疗抗体的生产。 GS Effex(R)细胞株是为了响应更先进的治疗性抗体的发展而带来的迫切市场需求而创建的。 GS Effex(R) 源自 Lonza 性能最佳的 GS Xceed(R)细胞株，与 Lonza 平台完美整合。当与强劲的细胞生长和产生有效治疗抗体的能力相结合时，这种独特的细胞株为从早期研究到商业生产的治疗开发提供了解决方案。

目录

第一章：重组抗体市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的重组抗体市场片段
    • 重组抗体市场片段（依应用）
    • 按国家/地区分類的重组抗体市场片段
    • 按地区分類的重组抗体市场片段
  • 竞争洞察

第 3 章：重组抗体主要市场趋势

  • 重组抗体市场驱动因素
    • 市场驱动因素的影响分析
  • 重组抗体市场限制
    • 市场限制影响分析
  • 重组抗体市场机会
  • 重组抗体市场未来趋势

第 4 章：重组抗体产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：重组抗体市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：重组抗体市场格局

  • 2023 年重组抗体市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：重组抗体市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 单股抗体
    • 全人源抗体
    • 人源化抗体
    • 嵌合抗体
    • 双特异性抗体

第 8 章：重组抗体市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 医院和诊断实验室
    • 製药与生物技术
    • 研究机构
    • 其他的

第 9 章：重组抗体市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美重组抗体主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲重组抗体主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区重组抗体主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲重组抗体主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲重组抗体主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 重组抗体产业

  • 竞争仪表板
  • 公司简介
    • Bio-Rad Laboratories
    • GE Healthcare
    • F. Hoffmann-La Roche
    • BIOLEGEND
    • BD Biosciences
    • Creative Biolabs
    • Merck KGaA
    • Abnova
    • Abcam
    • SinoBiological
    • BBI Solutions
    • ProMab Biotechnologies
    • Beckman Coulter

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2299

REPORT HIGHLIGHT

Recombinant Antibodies Market size was valued at USD 12,110 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Synthetic monoclonal antibodies, or recombinant antibodies, are created in vitro using recombinant DNA technology as a substitute for the traditional hybridoma-based approach of manufacturing monoclonal antibodies. Recombinant antibodies may be created without vaccinating animals since synthetic genes are employed to make them outside of the immune system. These synthetic antibodies are superior to traditional animal-derived antibodies in a number of respects and may be used in any application due to their high specificity, sensitivity, and repeatability.

Recombinant Antibodies Market- Market Dynamics

Increasing cases of cancer and infectious disease drives market growth

Over the projected period, the market for recombinant antibodies is anticipated to grow as a result of the rising incidence of infectious diseases and cancer cases worldwide. By identifying and attaching to antigens expressed on the surface of cancer cells, recombinant antibodies are engineered to precisely target cells that are cancerous. Compared to conventional chemotherapy, this focused approach reduces adverse effects and decreases harm to healthy cells. This may also be used to passive immunization, which offers instant defense against infectious pathogens. They can be given to those who are at danger or have been exposed to infections, such as in the event of certain viral epidemics, since they are made to resemble the immune response. For instance, according to estimates from the Global Cancer Observatory (GLOBOCAN), there will be 19.3 million incident cases of cancer globally in 2020. India placed third, behind the United States of America and China. 2.08 million new cases of cancer would be detected in India in 2040, up 57.5 percent from 2020.

Recombinant Antibodies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on type segmentation, the Single Chain Antibody segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the Pharmaceutical & Biotechnology segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Recombinant Antibodies Market- Segmentation Analysis:

The Global Recombinant Antibodies Market is segmented based on Type, Application and Region.

Based on the type, the Recombinant Antibodies market is bifurcated into Single Chain Antibody, Full Human Antibody, Humanized Antibody, Chimeric Antibody and Bispecific Antibody. The Single Chain Antibody segment is expected to capture the largest revenue share over the projected period. Recombinant DNA technology is used to manufacture single chain antibodies, enabling the modification of binding specificity and affinity. This characteristic increases their adaptability in focusing on particular antigens associated with a range of illnesses. Because of their smaller size and simpler structure than typical antibodies, scFv molecules are useful in some situations. greater tissue penetration may be made possible by their lower size, which might lead to greater therapeutic results.

Based on the application, the global Recombinant Antibodies market is segmented into Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes and Others. The Pharmaceutical & Biotechnology segment is expected to dominate the market over the projected period. Major pharmaceutical and biotechnology companies invest heavily in research and development activities related to recombinant antibodies. Thus, driving the segment expansion.

Recombinant Antibodies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The regional market expansion is attributed to the presence of major players. Additionally, the rising prevalence of cancer and others infectious disease significantly drive the market growth in the region.

Recombinant Antibodies Market- Competitive Landscape:

The key players operating in the market are Bio-Rad Laboratories, GE Healthcare, F. Hoffmann-La Roche, BIOLEGEND, BD Biosciences, Creative Biolabs, Merck KGaA, Abnova, Abcam, SinoBiological, BBI Solutions, ProMab Biotechnologies and Beckman Coulter. These players adopted various strategies to gain major market share in the industry including product launch, acquisition, collaboration and others.

Recent Developments:

In November 2023, Lonza declared the opening of its new GS Effex(R) cell line to facilitate the production of more potent therapeutic antibodies. The GS Effex(R) cell line was created in response to urgent market demands brought on by the move toward more advanced therapeutic antibodies. GS Effex(R), which is derived from Lonza's top-performing GS Xceed(R) cell line, integrates well with Lonza platforms. When coupled with robust cell growth and the capacity to generate potent therapeutic antibodies, this unique cell line offers a solution for therapeutic development spanning from early-stage research to commercial manufacture.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT ANTIBODIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bio-Rad Laboratories

GE Healthcare

F. Hoffmann-La Roche

BIOLEGEND

BD Biosciences

Creative Biolabs

Merck KGaA

Abnova

Abcam

SinoBiological

BBI Solutions

ProMab Biotechnologies

Beckman Coulter

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Single Chain Antibody
  • Full Human Antibody
  • Humanized Antibody
  • Chimeric Antibody
  • Bispecific Antibody

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology
  • Research Institutes
  • Others

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Recombinant Antibodies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Recombinant Antibodies Market Snippet by Type
    • 2.1.2.Recombinant Antibodies Market Snippet by Application
    • 2.1.3.Recombinant Antibodies Market Snippet by Country
    • 2.1.4.Recombinant Antibodies Market Snippet by Region
  • 2.2.Competitive Insights

3.Recombinant Antibodies Key Market Trends

  • 3.1.Recombinant Antibodies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Recombinant Antibodies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Recombinant Antibodies Market Opportunities
  • 3.4.Recombinant Antibodies Market Future Trends

4.Recombinant Antibodies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Recombinant Antibodies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Recombinant Antibodies Market Landscape

  • 6.1.Recombinant Antibodies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Recombinant Antibodies Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Single Chain Antibody
    • 7.1.3.Full Human Antibody
    • 7.1.4.Humanized Antibody
    • 7.1.5.Chimeric Antibody
    • 7.1.6.Bispecific Antibody

8.Recombinant Antibodies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Hospitals & Diagnostic Laboratories
    • 8.1.3.Pharmaceutical & Biotechnology
    • 8.1.4.Research Institutes
    • 8.1.5.Others

9.Recombinant Antibodies Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Recombinant Antibodies Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Recombinant Antibodies Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Recombinant Antibodies Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Recombinant Antibodies Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Recombinant Antibodies Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Recombinant Antibodies Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bio-Rad Laboratories
    • 10.2.2.GE Healthcare
    • 10.2.3.F. Hoffmann-La Roche
    • 10.2.4.BIOLEGEND
    • 10.2.5.BD Biosciences
    • 10.2.6.Creative Biolabs
    • 10.2.7.Merck KGaA
    • 10.2.8.Abnova
    • 10.2.9.Abcam
    • 10.2.10.SinoBiological
    • 10.2.11.BBI Solutions
    • 10.2.12.ProMab Biotechnologies
    • 10.2.13.Beckman Coulter

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Recombinant Antibodies Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Recombinant Antibodies Market, by Type 2019-2032 (USD Million)
  • TABLE Recombinant Antibodies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Recombinant Antibodies Market, by Application 2019-2032 (USD Million)
  • TABLE Recombinant Antibodies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Recombinant Antibodies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Recombinant Antibodies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Europe Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Asia Pacific Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Latin America Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Middle East and Africa Recombinant Antibodies Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Germany Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE India Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Brazil Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Saudi Arabia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)